| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2067147
[patent_doc_number] => 04459286
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1984-07-10
[patent_title] => 'Coupled H. influenzae type B vaccine'
[patent_app_type] => 1
[patent_app_number] => 6/462594
[patent_app_country] => US
[patent_app_date] => 1983-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6490
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/459/04459286.pdf
[firstpage_image] =>[orig_patent_app_number] => 462594
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/462594 | Coupled H. influenzae type B vaccine | Jan 30, 1983 | Issued |
Array
(
[id] => 2142175
[patent_doc_number] => 04499072
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-02-12
[patent_title] => 'Process for treating diseases with ODC inhibitors'
[patent_app_type] => 1
[patent_app_number] => 6/460224
[patent_app_country] => US
[patent_app_date] => 1983-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4525
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/499/04499072.pdf
[firstpage_image] =>[orig_patent_app_number] => 460224
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/460224 | Process for treating diseases with ODC inhibitors | Jan 23, 1983 | Issued |
Array
(
[id] => 2261331
[patent_doc_number] => 04564592
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-01-14
[patent_title] => 'Toxoplasmosis factor and production of same'
[patent_app_type] => 1
[patent_app_number] => 6/460057
[patent_app_country] => US
[patent_app_date] => 1983-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3900
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/564/04564592.pdf
[firstpage_image] =>[orig_patent_app_number] => 460057
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/460057 | Toxoplasmosis factor and production of same | Jan 20, 1983 | Issued |
Array
(
[id] => 2278366
[patent_doc_number] => 04626430
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1986-12-02
[patent_title] => 'Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom'
[patent_app_type] => 1
[patent_app_number] => 6/511418
[patent_app_country] => US
[patent_app_date] => 1983-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4985
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/626/04626430.pdf
[firstpage_image] =>[orig_patent_app_number] => 511418
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/511418 | Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom | Jan 18, 1983 | Issued |
Array
(
[id] => 2104083
[patent_doc_number] => 04483849
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1984-11-20
[patent_title] => 'Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product'
[patent_app_type] => 1
[patent_app_number] => 6/430755
[patent_app_country] => US
[patent_app_date] => 1983-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2020
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/483/04483849.pdf
[firstpage_image] =>[orig_patent_app_number] => 430755
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/430755 | Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product | Jan 6, 1983 | Issued |
| 06/455477 | VITRO AND IN VIVO TREATMENT OF CANCER CELLS AND TREATMENT OF VIRUSES WITH A TRIPEPTIDE COMPOUND | Jan 3, 1983 | Abandoned |
| 06/455517 | ANTITHROMBOTIC AGENT | Jan 3, 1983 | Abandoned |
Array
(
[id] => 2139387
[patent_doc_number] => 04493892
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-01-15
[patent_title] => 'Solvent system for peroxidase inhibitor reagent for fecal occult blood determinations'
[patent_app_type] => 1
[patent_app_number] => 6/451526
[patent_app_country] => US
[patent_app_date] => 1982-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1344
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/493/04493892.pdf
[firstpage_image] =>[orig_patent_app_number] => 451526
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/451526 | Solvent system for peroxidase inhibitor reagent for fecal occult blood determinations | Dec 19, 1982 | Issued |
Array
(
[id] => 2146786
[patent_doc_number] => 04497795
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-02-05
[patent_title] => 'Method of regulating appetite and efficiency of food utilization employing interferon'
[patent_app_type] => 1
[patent_app_number] => 6/448951
[patent_app_country] => US
[patent_app_date] => 1982-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6851
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/497/04497795.pdf
[firstpage_image] =>[orig_patent_app_number] => 448951
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/448951 | Method of regulating appetite and efficiency of food utilization employing interferon | Dec 12, 1982 | Issued |
| 06/447794 | NOVEL DNA AND RECOMBINANT PLASMID CONTAINING THE SAME | Dec 7, 1982 | Abandoned |
Array
(
[id] => 2196944
[patent_doc_number] => 04503036
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-03-05
[patent_title] => 'Process for producing a biochemical vaccine against Salmonella infection'
[patent_app_type] => 1
[patent_app_number] => 6/447503
[patent_app_country] => US
[patent_app_date] => 1982-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1829
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/503/04503036.pdf
[firstpage_image] =>[orig_patent_app_number] => 447503
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/447503 | Process for producing a biochemical vaccine against Salmonella infection | Dec 6, 1982 | Issued |
| 06/445583 | INTRAVENOUS OR INTRAPERITONEAL ADMINISTRATION OF A TRIPEPTIDE COMPOUND FOR TREATING CANCER | Nov 29, 1982 | Abandoned |
| 06/445349 | PROCESS FOR TREATING DISEASES WITH ODC INHIBITORS | Nov 28, 1982 | Abandoned |
Array
(
[id] => 2106713
[patent_doc_number] => 04472378
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1984-09-18
[patent_title] => 'Live vaccine for the prevention of salmonellosis in water fowl, a process for making and applying the same'
[patent_app_type] => 1
[patent_app_number] => 6/445272
[patent_app_country] => US
[patent_app_date] => 1982-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4561
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/472/04472378.pdf
[firstpage_image] =>[orig_patent_app_number] => 445272
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/445272 | Live vaccine for the prevention of salmonellosis in water fowl, a process for making and applying the same | Nov 28, 1982 | Issued |
| 06/443620 | PHARAMACEUTICAL COMPOSITION CONTAINING INTERFERON IN STABLE STATE | Nov 21, 1982 | Abandoned |
Array
(
[id] => 2149068
[patent_doc_number] => 04539205
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-09-03
[patent_title] => 'Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives'
[patent_app_type] => 1
[patent_app_number] => 6/439846
[patent_app_country] => US
[patent_app_date] => 1982-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 28
[patent_no_of_words] => 17314
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/539/04539205.pdf
[firstpage_image] =>[orig_patent_app_number] => 439846
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/439846 | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives | Nov 8, 1982 | Issued |
Array
(
[id] => 2071435
[patent_doc_number] => 04462986
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1984-07-31
[patent_title] => 'Synergistic anti-herpes compositions'
[patent_app_type] => 1
[patent_app_number] => 6/439121
[patent_app_country] => US
[patent_app_date] => 1982-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2553
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/462/04462986.pdf
[firstpage_image] =>[orig_patent_app_number] => 439121
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/439121 | Synergistic anti-herpes compositions | Nov 3, 1982 | Issued |
| 06/438641 | LIVE VACCINE FOR BOVINE BABESIOSIS AND METHOD OF PREPARATION | Nov 2, 1982 | Abandoned |
Array
(
[id] => 2198808
[patent_doc_number] => 04534906
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1985-08-13
[patent_title] => 'Removal of impurities from human leukocyte interferon preparations'
[patent_app_type] => 1
[patent_app_number] => 6/438129
[patent_app_country] => US
[patent_app_date] => 1982-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 2868
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/534/04534906.pdf
[firstpage_image] =>[orig_patent_app_number] => 438129
[rel_patent_id] =>[rel_patent_doc_number] =>) 06/438129 | Removal of impurities from human leukocyte interferon preparations | Oct 31, 1982 | Issued |
| 06/438128 | ANIMAL INTERFERONS | Oct 31, 1982 | Abandoned |